Best Oral Antibiotic for Pediatric Impetigo
Cephalexin 25–50 mg/kg/day divided into 3–4 doses for 7 days is the first-line oral antibiotic for uncomplicated impetigo in children when systemic therapy is required. 1, 2
When Oral Antibiotics Are Indicated
- Reserve oral antibiotics for extensive disease (numerous lesions, involvement of multiple body areas) or when topical mupirocin has failed or is impractical. 1, 2
- For limited impetigo (few lesions), topical mupirocin 2% ointment applied three times daily for 5 days is superior to oral therapy and should be used first-line. 1, 2
First-Line Oral Agent: Cephalexin
Cephalexin provides excellent coverage for both Staphylococcus aureus and Streptococcus pyogenes, the two primary pathogens in impetigo. 1, 2
Dosing
- Pediatric dose: 25–50 mg/kg/day divided every 6–8 hours (maximum 500 mg per dose) for 7 days 1, 2
- The liquid suspension formulation and straightforward dosing schedule make cephalexin particularly practical for children. 2
Why Cephalexin Is Preferred
- A 1990 comparative trial demonstrated cephalexin had 0% treatment failure versus 24% failure with penicillin V and 4% with erythromycin. 3
- Cephalexin is more effective than penicillin because S. aureus (the predominant pathogen in 62–81% of cases) is resistant to penicillin. 4, 3
Alternative First-Line Agent: Amoxicillin-Clavulanate
Amoxicillin-clavulanate 40–50 mg/kg/day divided three times daily for 7 days is an acceptable alternative preferred oral agent when cephalexin is unavailable or not tolerated. 1, 5
When to Suspect MRSA and Adjust Therapy
Switch from cephalexin to an MRSA-active agent if the patient has:
- Purulent drainage from lesions 1, 2
- Lack of clinical response after 48–72 hours of beta-lactam therapy 1
- Known MRSA colonization or lives in a community with CA-MRSA prevalence >10% 1, 2
MRSA-Active Oral Options
Clindamycin 10–13 mg/kg/dose every 6–8 hours (maximum 40 mg/kg/day) for 7 days is the preferred single-agent MRSA coverage, provided local clindamycin resistance rates are <10%. 1, 2
Trimethoprim-sulfamethoxazole 4–6 mg/kg/dose (based on trimethoprim component) twice daily for 7 days covers MRSA but must be combined with a beta-lactam (cephalexin or amoxicillin-clavulanate) because it lacks reliable streptococcal coverage. 1, 2
Doxycycline 2–4 mg/kg/day divided twice daily for 7 days may be used for MRSA in children >8 years old only; avoid in younger children due to permanent dental staining risk. 2
Agents to Avoid
Do not use penicillin V as monotherapy—it is seldom effective because S. aureus now causes the majority of impetigo cases and is penicillin-resistant. 2, 6
Do not use amoxicillin alone—it lacks adequate anti-staphylococcal coverage. 2
Do not use trimethoprim-sulfamethoxazole as monotherapy—it does not reliably cover S. pyogenes. 1, 2
Erythromycin 30–40 mg/kg/day divided three times daily has comparable efficacy to cephalexin historically, but macrolide resistance now affects 8–9% of S. pyogenes isolates, limiting its reliability. 1
Treatment Duration and Monitoring
- A 7-day course is standard for oral antibiotics; do not shorten to 5 days as this increases failure risk. 1, 2
- Re-evaluate within 24–48 hours of starting therapy to confirm clinical improvement; early failure suggests resistant organisms requiring therapy adjustment. 1
Penicillin Allergy Considerations
- Cephalexin may be used in non-immediate penicillin hypersensitivity (cross-reactivity <5%). 2
- For immediate hypersensitivity reactions (anaphylaxis, angioedema, urticaria), use clindamycin instead. 2
Critical Pitfalls to Avoid
- Do not prescribe oral antibiotics for limited impetigo when topical mupirocin would be more effective. 1, 2
- Do not use cephalexin when MRSA is documented or strongly suspected—it lacks MRSA activity. 2
- Do not assume beta-lactams will work in high CA-MRSA prevalence areas without considering empiric MRSA coverage. 2, 7